NEXXCOV Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for NEXXCOV with the United States Patent and Trademark Office. The USPTO has given the NEXXCOV trademark a serial number of 98787840. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, February 18, 2025. This trademark is owned by ModernaTx, Inc.. The NEXXCOV trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
nexxcov

General Information


Serial Number98787840
Word MarkNEXXCOV
Filing DateMonday, October 7, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Monday, October 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 13, 2025ASSIGNED TO EXAMINER
Tuesday, February 18, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, February 18, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 18, 2025SUSPENSION LETTER WRITTEN

Related Keywords


nexxcov human vaccines